Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients

Table 5 Multiple Cox Regression Analysis for OS in a cohort of liver transplantation.

Variable	p	Hazard Ratio (CI)
AGE (CONTINUOUS VARIABLE)	0.059
PARTIAL GRAFT (YES/NO)	0.919
DONOR TYPE (LIVE OR DECEASED)	0.500
CAUSE OF LIVER TRANSPLANTATION	0.719
TOXICITY AS EVENT POST-TRANSPLANT	0.479
LIVER DISEASE RELAPSE AS EVENT POST-TRANSPLANT	< 0.001	6.609 (2.674-16.335)
THROMBOSIS AS EVENT POST-TRANSPLANT	0.600
TUMOR AS EVENT POST-TRANSPLANT	0.303
FVIII LEVEL RECIPIENT(CONTINUOUS VARIABLE)	0.019	1.008 (1.001-1.015)
ANTITHROMBIN LEVEL RECIPIENT (CONTINUOUS VARIABLE)	< 0.001	0.946 (0.921-0.971)
PROTEIN C RECIPIENT	0.931
PROTEIN S RECIPIENT	0. 388
FIBRINOGEN LEVEL RECIPIENT	0.264
PLATELET COUNT RECIPIENT	0.233

Relapse of liver disease (HR 6.609), high levels of FVIII (HR 1.0008) and low levels of antithrombin (HR 0.946) have been independently associated with mortality from the time of liver transplantation in a multivariable Cox regression model. Split Liver Transplant: In some cases, it is possible to divide the donor liver into two parts and transplant the parts into two recipients or in the case of the live donor liver transplant too.

ISSN: 1471-230X